PRIMUS PHARMACEUTICALS INC has a total of 21 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LEUKOS BIOTECH S L, QUEST PHARMACEUTICAL SERVICES and Shionogi Inc.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Levy Robert M | 6 |
#2 | Squadrito Francesco | 6 |
#3 | Levy Robert | 5 |
#4 | Bitto Alessandra | 4 |
#5 | Yamaguchi Masayoshi | 4 |
#6 | Vita Giuseppe | 4 |
#7 | Burnett Bruce P | 4 |
#8 | Messina Sonia | 4 |
#9 | Altavilla Domenica | 2 |
#10 | Gande Mukteeshwar | 2 |
Publication | Filing date | Title |
---|---|---|
US2020405693A1 | Reduced dose metaxalone formulations | |
US2019380999A1 | Combinations of genistein and bisphosphonates | |
KR20200051579A | Methods for the treatment of autoimmune microvascular disorders | |
US2018064681A1 | Therapeutic combinations of curcuminoids and flavonoids | |
US2017273912A1 | Methods and formulations for supporting and promoting bone health | |
US2017136052A1 | Therapeutic combinations of curcuminoids and flavonoids | |
US2017112802A1 | Therapeutic combinations of sesquiterpenes and flavonoids | |
US2013078318A1 | Combination dosage forms and therapies for supporting bone health | |
US2010190733A1 | Methods of Treating Muscular Dystrophies |